- \n
- Chemistry<\/em><\/li>\n\n\n\n
- Biotechnology \/ Pharma<\/em><\/li>\n<\/ul>\n\n\n\n
<\/p>\n\n\n\n
- \n
- Recycling, renewable resources<\/em><\/li>\n\n\n\n
- Hydrogen technology\/energy technology\/battery technology\/e-fuels<\/em><\/li>\n\n\n\n
- Industrial processes, consumer goods<\/em><\/li>\n\n\n\n
- Composite materials, plastics technology, materials technology<\/em><\/li>\n\n\n\n
- Metallurgy, wastewater technology<\/em><\/li>\n<\/ul>\n\n\n\n
<\/p>\n\n\n\n
- \n
- as well as in related fields such as Computer Implemented Inventions (CII), Artificial Intelligence<\/em> (AI)<\/li>\n<\/ul>\n\n\n\n
IP rights are developed together with the inventors. Beforehand, the core of your innovation is jointly identified in order to be able to claim it in the best possible way. We determine the IP strategy together according to your needs in terms of territorial scope and costs as well as duration of protection and enforceability.<\/p>\n\n\n\n
Dr. D\u00e4britz is a partner in the law and patent law firm Dinter, Krei\u00dfig & Partner mbB<\/a>.<\/p>\n\n\n\n
![\"Dr.](\"https:\/\/daebritz-pmd.eu\/wp-content\/uploads\/2021\/11\/256791669_866158864091246_5041890887309955788_n.jpg\")
<\/span>\n<\/p>\n<\/div><\/div>\n\n\n\n
<\/p>\n\n\n\n
CV<\/strong><\/p>\n\n\n\n
Dr. Frank D\u00e4britz studied chemistry at the TU Dresden,<\/a> with specialisation in organic chemistry and polymer chemistry. During his studies he completed a research internship of several months at the WWU M\u00fcnster<\/a> on the topic of X-ray crystal structure analysis. In his diploma thesis, he investigated in<\/em>-phosphane macrobicycles and the reactivity of their in<\/em>-electron pairs.<\/p>\n\n\n\n
In 2008, he began his PhD under Prof. Dr. Voit at the Leibniz Institute of Polymer Research Dresden<\/a> in the field of macromolecular chemistry and completed in 2011 with the thesis \"Hyperstar polymers - their synthesis, characterisation and application as reactive binders in photoresists and thermosets<\/em>\".<\/p>\n\n\n\n
Subsequently, he worked for several years in project management<\/em> and in business development<\/em> in various chemical and biotechnological companies - in Dresden for a chemical manufacturer of active pharmaceutical ingredients<\/a>, in Hamburg for a drug development company<\/a> and in Berlin for a biotech company in the field of monoclonal antibodies<\/a>.<\/p>\n\n\n\n
During 2018 and 2021, he completed the training for admission as a patent attorney at the patent law firm Kailuweit & Uhlemann.<\/p>\n\n\n\n
As part of his training, he attended the course \"Law for Patent Attorneys<\/em>\" and later \u201eEuropean Patent Litigation Certificate (EPLC)\u201c<\/em> at Fernuniversit\u00e4t Hagen<\/a>. In addition, he completed an internship at the Hamburg District Court<\/a> and stations at the Federal Patent Court<\/a> and the German Patent and Trade Mark Office<\/a> in Munich.<\/p>\n\n\n\n
Due to his interdisciplinary education, Dr. D\u00e4britz has broad scientific and technical competences.<\/p>\n\n\n\n
His working languages are German and English.<\/p>\n\n\n\n
Approvals<\/strong><\/p>\n\n\n\n
Dr. D\u00e4britz is admitted to represent clients before the:<\/p>\n\n\n
- Hydrogen technology\/energy technology\/battery technology\/e-fuels<\/em><\/li>\n\n\n\n
- Biotechnology \/ Pharma<\/em><\/li>\n<\/ul>\n\n\n\n